Dieses Element beschreibt den Namen der Krankheit, gegen die
geimpft wird. Es handelt sich um ein mehrfach auswählbares
Element, da ein Impfstoff mehrere einzelne Wirkstoffe enthalten
kann und somit mehrere Erkrankungen, gegen die geimpft wird,
adressiert werden können.
! ! Reminder intern: Zuordnung der Kombiimpfstoffe zu den
jeweiligen Erkrankungen in Confluence und FHIR Umsetzung !
!
Kardinalität und Konformität:
| SZENARIO | KARDINALITÄT | KONFORMITÄT |
|---|
Rationale:
§ 22 Absatz 2 Nr. 3 Infektionsschutzgesetz
Der Impfausweis oder die Impfbescheinigung muss über jede Schutzimpfung enthalten:
- Name der Krankheit, gegen die geimpft wird
Operationalisierungshinweis:
Es sollen ein oder mehrere SNOMED CT ® Codes (Disease Codes) eingetragen werden. Die weiteren Codesysteme sind ausschließlich zum Mapping mit diesen angegeben. Bei der Auswahl eines Kombinationsimpfstoffes ( mit einemATC-Code und SNOMED CT® Product Code) werden mehrere Erkrankungen, gegen die geimpft wird, adressiert, daher sind die Codes für die Kombinationsimpfstoffe mehrfach zugeordnet.
FHIR®-Mapping:
- KBV_PR_AW_Impfung.protocolApplied.targetDisease.coding.code
- KBV_PR_AW_Impfung.protocolApplied.targetDisease.coding.system
- KBV_PR_AW_Impfung.protocolApplied.targetDisease.coding.version
- KBV_PR_AW_Impfung.protocolApplied.targetDisease.coding.display
Wert: Code
| KONZEPT UND WIEDERGABENAME | CODE | BEZEICHNUNG IM CODE-SYSTEM | CODE-SYSTEM | WERTELISTE |
|---|---|---|---|---|
| Infektionskrankheit (unspezifiziert, hier nicht gelistet) | 787859002 | Vaccine product (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine |
| 40733004 | Infectious disease (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Erkrankung - Notwendigkeit für Immunglobulingabe | 714569001 | Product containing normal immunoglobulin human (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine_Immunoglobulin |
| 64572001 | Disease (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Rh-Unverträglichkeit bei Schwangerschaft | I109141 | Rh-Unverträglichkeit bei Schwangerschaft | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 786224004 | Product containing human anti-D immunoglobulin (medicinal product)| | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine_Immunoglobulin | |
| 307333004 | Rhesus isoimmunization due to anti-D (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| COVID-19 o.n.A. | I130800 | COVID-19 o.n.A. | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 840539006 | Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 1119305005 | Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| 1119349007 | Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| Zytomegalieviren-Infektion | I130677 | Zytomegalieviren-Infektion | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 9778000 | Product containing Cytomegalovirus antibody (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine_Immunoglobulin | |
| 28944009 | Cytomegalovirus infection (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Respiratory-Syncytial-Viren-Infektion | I130678 | Respiratory-Syncytial-Viren-Infektion | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 55735004 | Respiratory syncytial virus infection (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 108725001 | Product containing palivizumab (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine_Immunoglobulin | |
| Clostridioides-difficile-Infektion | I130668 | Clostridioides-difficile-Infektion | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 763703008 | Product containing bezlotoxumab (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine_Immunoglobulin | |
| 186431008 | Clostridioides difficile infection (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Pocken | I15064 | Pocken | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 836389008 | Vaccine product containing Vaccinia virus antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| 67924001 | Smallpox (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| HPV [Humanes Papillomavirus]-Infektion | I130676 | HPV [Humanes Papillomavirus]-Infektion | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 240532009 | Human papillomavirus infection (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 836379009 | Vaccine product containing Human papillomavirus antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| Gelbfieber | I14036 | Gelbfieber | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 836385002 | Vaccine product containing Yellow fever virus antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| 16541001 | Yellow fever (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Herpes zoster | I23144 | Herpes zoster | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 4740000 | Herpes zoster (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 407737004 | NOT_FOUND | SNOMED Clinical Terms | NOT_FOUND | |
| Windpocken | I15579 | Windpocken | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 62294009 | Product containing Varicella-zoster virus antibody (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine_Immunoglobulin | |
| 407746005 | NOT_FOUND | SNOMED Clinical Terms | NOT_FOUND | |
| 38907003 | Varicella (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Röteln | I15222 | Röteln | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 36653000 | Rubella (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 836393002 | Vaccine product containing Rabies lyssavirus antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| Rotaviren-Infektion | I130669 | Rotaviren-Infektion | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 18624000 | Disease caused by Rotavirus (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 836387005 | Vaccine product containing Rotavirus antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| Tollwut | I22407 | Tollwut | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 14168008 | Rabies (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 80834004 | Product containing rabies human immune globulin (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine_Immunoglobulin | |
| Poliomyelitis | I14372 | Poliomyelitis | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 111164008 | NOT_FOUND | SNOMED Clinical Terms | NOT_FOUND | |
| 398102009 | Acute poliomyelitis (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Mumps | I14707 | Mumps | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 36989005 | Mumps (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 90043005 | NOT_FOUND | SNOMED Clinical Terms | NOT_FOUND | |
| Masern | I14609 | Masern | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 386012008 | NOT_FOUND | SNOMED Clinical Terms | NOT_FOUND | |
| 14189004 | Measles (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Hepatitis A | I15771 | Hepatitis A | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 40468003 | Viral hepatitis, type A (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 836375003 | Vaccine product containing Hepatitis A virus antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| Hepatitis B | I15777 | Hepatitis B | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 9542007 | Product containing Hepatitis B surface antigen immunoglobulin (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine_Immunoglobulin | |
| 836374004 | Vaccine product containing Hepatitis B virus antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| 66071002 | Viral hepatitis type B (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Grippe [Influenza] | I14083 | Grippe [Influenza] | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 836377006 | Vaccine product containing Influenza virus antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| 6142004 | Influenza (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Japanische Enzephalitis | I1064 | Japanische Enzephalitis | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 52947006 | Japanese encephalitis virus disease (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 836378001 | Vaccine product containing Japanese encephalitis virus antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| FSME [Zentraleuropäische Frühsommer-Meningoenzephalitis] | I23483 | FSME [Zentraleuropäische Frühsommer-Meningoenzephalitis] | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 16901001 | Central European encephalitis (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 836403007 | Vaccine product containing Tick-borne encephalitis virus antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| Typhus | I22454 | Typhus | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 89428009 | NOT_FOUND | SNOMED Clinical Terms | NOT_FOUND | |
| 4834000 | Typhoid fever (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Tuberkulose | I22433 | Tuberkulose | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 836402002 | Vaccine product containing live attenuated Mycobacterium bovis antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| 56717001 | Tuberculosis (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Tetanus-Infektion | I15432 | Tetanus-Infektion | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 76902006 | Tetanus (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 333621002 | NOT_FOUND | SNOMED Clinical Terms | NOT_FOUND | |
| 384706007 | Product containing tetanus antitoxin (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine_Immunoglobulin | |
| Pneumokokken-Infektion | I130672 | Pneumokokken-Infektion | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 16814004 | Pneumococcal infectious disease (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 333598008 | NOT_FOUND | SNOMED Clinical Terms | NOT_FOUND | |
| Pest | I15008 | Pest | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 58750007 | Plague (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 840549009 | Vaccine product containing Yersinia pestis antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| Pertussis | I14368 | Pertussis | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 61602008 | NOT_FOUND | SNOMED Clinical Terms | NOT_FOUND | |
| 27836007 | Pertussis (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Meningokokken-Infektion | I130671 | Meningokokken-Infektion | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 423531006 | NOT_FOUND | SNOMED Clinical Terms | NOT_FOUND | |
| 23511006 | Meningococcal infectious disease (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Haemophilus-influenzae-Typ-B-Infektion | I130674 | Haemophilus-influenzae-Typ-B-Infektion | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 333680004 | NOT_FOUND | SNOMED Clinical Terms | NOT_FOUND | |
| 709410003 | Haemophilus influenzae type b infection (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Diphtherie | I23502 | Diphtherie | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 428214002 | NOT_FOUND | SNOMED Clinical Terms | NOT_FOUND | |
| 397430003 | Diphtheria caused by Corynebacterium diphtheriae (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| Cholera | I13614 | Cholera | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 836383009 | Vaccine product containing Vibrio cholerae antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| 63650001 | Cholera (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 836383009 + 836390004 | Vaccine product containing Vibrio cholerae antigen (medicinal product) + Vaccine product containing Salmonella enterica subspecies enterica serovar Typhi antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| Brucellose | I13550 | Brucellose | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 75702008 | Brucellosis (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 7230005 | Brucella vaccine (product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine_Brucella | |
| Milzbrand | I14685 | Milzbrand | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 409498004 | Anthrax (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 836384003 | Vaccine product containing Bacillus anthracis antigen (medicinal product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine | |
| Fleckfieber | I13965 | Fleckfieber | 1.2.276.0.76.5.504, 2021 | KBV_VS_MIO_Vaccination_TargetDisease_AlphaID |
| 39111003 | Louse-borne typhus (disorder) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_TargetDisease | |
| 37146000 | Typhus vaccine (product) | SNOMED Clinical Terms | KBV_VS_AW_ImpfungVaccination_Vaccine |
Kommentierungen
KEINE INHALTE VORHANDEN
